Pharmaceutical care program for patients with reactive airways disease

Area of Science:

• Pharmaceutical Care
• Respiratory Medicine
• Community Pharmacy Practice

Background:

• Reactive airways disease (RAD) management requires comprehensive patient care.
• Community pharmacies are increasingly involved in patient care programs.
• Existing programs may not fully address the needs of RAD patients or pharmacists.

Purpose of the Study:

• To describe the development and implementation of a pharmaceutical care program for RAD patients.
• To evaluate the program's impact on patient outcomes and pharmacist job satisfaction.
• To identify key components and guiding principles for successful pharmaceutical care implementation in community settings.

Main Methods:

• A pharmaceutical care program was developed and implemented across 36 CVS pharmacies.
• A controlled trial involving over 1100 patient enrollees is evaluating the program's impact.
• The program incorporates patient-specific data, tailored education, resource guides, reinforcement strategies, and pharmacist training.

Main Results:

• The program's impact on patient outcomes and pharmacist job satisfaction is currently under evaluation.
• Key program components include patient-specific data display, tailored education materials, and resource guides.
• Guiding principles emphasize clinically relevant data, pharmacist training, addressing organizational barriers, and ongoing support.

Conclusions:

• The developed pharmaceutical care program is designed for community pharmacies serving patients with reactive airways disease.
• The program's structure and components are adaptable to various ambulatory care pharmacy practices.
• Ongoing evaluation will determine the program's effectiveness in improving patient care and pharmacist roles.